A central characteristic shared by ALPS patients and lpr/lpr Fas-deficient mice is the development of lymphoproliferative disease, characterized by splenomegaly, lymphadenopathy and accumulation of CD4−CD8− DN T cells3, 4. The gene discussed is FAS; the disease is Lymphadenopathy.